Over 25 companies and 15 academic institutions collaborated together with government agencies to produce a national roadmap on cell therapy manufacturing. The National Cell Manufacturing Consortium (NCMC) is the first U.S. based national consortium focused on developing, maturing, and implementing technologies that can enable large-scale, cost-effective manufacturing of therapeutic cells.
NCMC is established through the Advanced Manufacturing Technologies (AMTech) grant from the National Institute of Standards and Technologies (NIST).